1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. XILIO THERAPEUTICS INC
Xilio Therapeutics Inc
XNAS: XLO
9.01 0.10 (1.12%)
7,400
XNAS Volume

XNAS 02 Oct, 2026 5:30 PM (EDT)

Watchlist

Portfolio

Alert

Xilio Therapeutics Inc - XLO - stock price prediction, stock price target, analyst ratings from 1 analyst

Xilio Therapeutics Inc has a share price target of US$ 20, revenue growth forecast of -11.7%, for FY26, based on top 1 analyst call.